Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children
Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
Little is known about what treatment combinations are best for HIV infected children. This
study examined the long-term effectiveness of different anti-HIV drug combinations in
children and strategies for switching treatment if the first treatment does not work. The
study enrolled children who had not previously taken anti-HIV medication. Participants in
this study were recruited in the United States, South America and Europe.
Some European children may also enroll in a substudy that will observe changes in body fat in
children taking anti-HIV medications.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) PENTA Foundation